跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 57 条关于
“Viaskin”
全部
57
临床试验
25
药物
16
机构
2
资讯
14
去年
DBV Technologies Advances Viaskin Peanut Patch with FDA and EMA Support
去年
DBV Technologies Launches $150M ATM Program to Fund VIASKIN Peanut Patch BLA Submissions
去年
DBV Technologies Initiates COMFORT Toddlers Phase 3 Study for Viaskin Peanut Patch in Young Children
去年
DBV Technologies Establishes $150 Million At-The-Market Program to Fund VIASKIN Peanut Patch Development
10个月前
DBV Technologies Appoints Kevin Trapp as Chief Commercial Officer Ahead of Viaskin Peanut Patch BLA Submission
4年前
DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers
去年
DBV Technologies Concludes VITESSE Trial Screening for Viaskin Peanut Patch
3年前
Viaskin Peanut Allergy Patch Shows Promise in Toddlers
2个月前
DBV Technologies Renews $150 Million At-The-Market Offering Program to Fund VIASKIN® Peanut Development and Pre-Commercial Activities
去年
Viaskin Peanut Patch Shows Promise in Toddlers with Peanut Allergy, Gains FDA Accelerated Approval Pathway
第 1 页,共 2 页
上一页
下一页